Which hedge funds own CGON? CG ONCOLOGY INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
4 of the hedge funds tracked by WhaleCreep disclosed a position in CGON (CG ONCOLOGY INC) in their Q2 2026 13F filings, worth $141.1m in total. The largest holder by portfolio weight is Avidity Partners at 15.9% of its book. 1 manager opened a new position this quarter: Marshall Wace. 1 exited: Brevan Howard Capital Management.
4tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold CGON? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Avidity Partners | Q2 2026 | 15.9% | $99.4m | 1,398,948 | 9% | added |
| Woodline Partners | Q2 2026 | 0.1% | $35.0m | 492,891 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $6.4m | 89,417 | 92% | added |
| Marshall Wace | Q2 2026 | 0.0% | $297.3k | 4,185 | – | new |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.1% | $785.0k |
How has hedge fund ownership of CGON changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $141.1m |
| Q1 2026 | 7 | $208.9m |
| Q4 2025 | 4 | $88.2m |
| Q3 2025 | 4 | $149.2m |
| Q2 2025 | 5 | $95.1m |
| Q1 2025 | 3 | $83.6m |
| Q4 2024 | 3 | $58.4m |
| Q3 2024 | 5 | $167.6m |
| Q2 2024 | 5 | $106.5m |
| Q1 2024 | 6 | $190.7m |
Counts every tracked manager that disclosed CGON in that quarter's filing, including managers that have since stopped filing.